70522 Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Brain Trauma & Imaging. 

Date: December 11, 2006. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS, Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529. 301–

594–0635. rc218u@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Cognition and Imaging. 

Date: December 18, 2006. 

Time: 11 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call). 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS, Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529. 301–

594–0635.rc218u@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Epilepsy Clinical Trial. 

Date: December 20, 2006. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Katherine Woodbury, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, NINDS/NIH/DHHS, 

Neuroscience Center, 6001 Executive Blvd., 

Suite 3208, MSC 9529, Bethesda, MD 20892–

9529. 301–496–5980. kw47o@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: November 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9529 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Vitamin D 

and Colon Cancer. 

Date: December 5, 2006. 

Time: 11 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call). 

Contact Person: Sally A. Mulhern, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6198, 

MSC 7804, Bethesda, MD 20892. (301) 435–

5877. mulherns@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel Member 

Conflict: Neurophysiology devices 

Neuroprosthetics. 

Date: December 13, 2006. 

Time: 9 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Vinod Charles, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5196, 

MSC 7846, Bethesda, MD 20892. (301) 435–

0902. charlesvi@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Review 

Member Applications on Neurodegeneration. 

Date: December 18, 2006. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Toby Behar, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4136, 

MSC 7850, Bethesda, MD 20892. (301) 435–

4433. behart@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Continued 

Development and Maintenance of Software. 

Date: January 8, 2007. 

Time: 8:45 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037. 

Contact Person: Malgorzata Klosek, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7849, Bethesda, MD 20892. (301) 435–

2211. klosekm@csr.nih.gov. 

Name of Committee: Surgical Sciences, 

Biomedical Imaging and Bioengineering 

Integrated Review Group, Surgery, 

Anesthesiology and Trauma Study Section. 

Date: January 24–25, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Weihua Luo PhD, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5114 

MSC 7854, Bethesda, MD 20892. 301–435–

1170. luow@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group, Enabling Bioanalytical and 

Biophysical Technologies Study Section. 

Date: January 31–February 1, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Marriott, 299 Second 

Street, San Francisco, CA 94105. 

Contact Person: Vonda K. Smith, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4148, 

MSC 7806, Bethesda, MD 20892. 301–435–

1789. smithvo@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


ycherry on PROD1PC64 with NOTICES
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices 70523 

Dated: November 28, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–9527 Filed 12–4–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Regulations to Implement 

SAMHSA’s Charitable Choice 

Statutory Provisions—42 CFR parts 54 

and 54a (OMB No. 0930–0242)—

Revision 

Section 1955 of the Public Health 

Service Act (42 U.S.C. 300x–65), as 

amended by the Children’s Health Act 

of 2000 (Pub. L. 106–310) and Sections 

581–584 of the Public Health Service 

Act (42 U.S.C. 290kk et seq., as added 

by the Consolidated Appropriations Act 

(Pub. L. 106–554)), set forth various 

provisions which aim to ensure that 

religious organizations are able to 

compete on an equal footing for Federal 

funds to provide substance abuse 

services. These provisions allow 

religious organizations to offer 

substance abuse services to individuals 

without impairing the religious 

character of the organizations or the 

religious freedom of the individuals 

who receive the services. The provisions 

apply to the Substance Abuse 

Prevention and Treatment Block Grant 

(SAPT BG), to the Projects for 

Assistance in Transition from 

Homelessness (PATH) formula grant 

program, and to certain Substance 

Abuse and Mental Health Services 

Administration (SAMHSA) 

discretionary grant programs (programs 

that pay for substance abuse treatment 

and prevention services, not for certain 

infrastructure and technical assistance 

activities). Every effort has been made to 

assure that the reporting, recordkeeping 

and disclosure requirements of the 

proposed regulations allow maximum 

flexibility in implementation and 

impose minimum burden. 

No changes are being made to the 

regulations. This revision is for approval 

of the annual checklists to be completed 

by discretionary and PATH grantees to 

provide the information required to be 

reported by 42 CFR part 54a.8(d) and 

54.8(e), respectively, and to ascertain 

how they are implementing the 

disclosure requirements of 54a.8(b) and 

54.8(b), respectively. Information on 

how States comply with the 

requirements of 42 CFR part 54a was 

approved by the Office of Management 

and Budget (OMB) as part of the 

Substance Abuse Prevention and 

Treatment Block Grant FY 2005–2007 

annual application and reporting 

requirements approved under OMB 

control number 0930–0080. 

42 CFR Citation and purpose Number of 

respondents 

Responses 

per 

respondent 

Hours per 

response Total hours 

Part 54—States Receiving SAPT Block Grants and/or Projects for Assistance in Transition from Homelessness 

Reporting: 

96.122(f)(5) Annual report of activities the State undertook to comply 

42 CFR Part 54 ..................................................................................... 60 1 2 120 

54.8(c)(4) Program participant notification to responsible unit of government regarding referrals to alternative service providers ..................... 3 24 2.00 48 

54.8(e) Annual report by PATH grantees on activities undertaken to 

comply with 42 CFR Part 54 ................................................................. 56 1 2.00 112 

Disclosure: 

54.8(b) Program participant notice to program beneficiaries of rights 

to referral to an alternative service provider.

SAPT BG .................................................................................................. 60 10 .05 300 

PATH ........................................................................................................ 56 84 .05 236 

Recordkeeping: 

54.6(b) Documentation must be maintained to demonstrate significant 

burden for program participants under 42 U.S.C. 300x–57 or 42 

U.S.C. 290cc–33(a)(2) .......................................................................... 60 1 1.00 60 

Part 54—Subtotal .............................................................................. 181 ........................ ........................ 876 

Part 54a—States, local governments and religious organizations receiving funding under Title V of the PHS Act for substance abuse 

prevention and treatment services 

Reporting: 

54a.8(c)(1)(iv) Program participant notification to State or local government of a referral to an alternative provider ......................................... 25 4 .083 8 

54a(8)(d) Program participant notification to SAMHSA of referrals ......... 20 2 .25 10 

Disclosure: 

54a.8(b) Program participant notice to program beneficiaries of rights to 

referral to an alternative service provider ............................................. 1,460 1 1.0 1,460 

Part 54a—Subtotal ................................................................................ 1,505 ........................ ........................ 1,478 

Total ........................................................................................... 1,686 ........................ ........................ 2,354 


ycherry on PROD1PC64 with NOTICES